BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hernández-Breijo B, Monserrat J, Ramírez-Rubio S, Cuevas EP, Vara D, Díaz-Laviada I, Fernández-Moreno MD, Román ID, Gisbert JP, Guijarro LG. Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma. World J Gastroenterol 2011; 17(34): 3899-3911 [PMID: 22025878 DOI: 10.3748/wjg.v17.i34.3899]
URL: https://www.wjgnet.com/1007-9327/full/v17/i34/3899.htm
Number Citing Articles
1
Laïla-Aïcha Hanafi, Dominique Gauchat, Jessica Godin-Ethier, David Possamaï, Jean-Baptiste Duvignaud, Denis Leclerc, Nathalie Grandvaux, Réjean Lapointe, Michael Platten. Fludarabine Downregulates Indoleamine 2,3-Dioxygenase in Tumors via a Proteasome-Mediated Degradation MechanismPLoS ONE 2014; 9(6): e99211 doi: 10.1371/journal.pone.0099211
2
Minjong Lee, Ara Jo, Seulki Lee, Jong Bin Kim, Young Chang, Joon Yeul Nam, Hyeki Cho, Young Youn Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim, Yuan-Soon Ho. 3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cellsPLOS ONE 2017; 12(3): e0174271 doi: 10.1371/journal.pone.0174271
3
Jinda Bian, Dan Zhang, Yicun Wang, Hanjiao Qin, Wei Yang, Ranji Cui, Jiyao Sheng. Mitochondrial Quality Control in Hepatocellular CarcinomaFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.713721
4
Luis G. Guijarro, Patricia Sanmartin-Salinas, Eva Pérez-Cuevas, M. Val Toledo-Lobo, Jorge Monserrat, Sofia Zoullas, Miguel A. Sáez, Miguel Angel Álvarez-Mon, Julia Bujan, Fernando Noguerales-Fraguas, Eduardo Arilla-Ferreiro, Melchor Álvarez-Mon, Miguel A. Ortega. Actinomycin D Arrests Cell Cycle of Hepatocellular Carcinoma Cell Lines and Induces p53-Dependent Cell Death: A Study of the Molecular Mechanism Involved in the Protective Effect of IRS-4Pharmaceuticals 2021; 14(9): 845 doi: 10.3390/ph14090845
5
Michael Andresini, Arianna Tota, Leonardo Degennaro, James A. Bull, Renzo Luisi. Synthesis and Transformations of NH‐SulfoximinesChemistry – A European Journal 2021; 27(69): 17293 doi: 10.1002/chem.202102619
6
Xinlong Zang, Jinxiao Song, Yanfeng Li, Yantao Han. Targeting necroptosis as an alternative strategy in tumor treatment: From drugs to nanoparticlesJournal of Controlled Release 2022; 349: 213 doi: 10.1016/j.jconrel.2022.06.060
7
Nicola Traverso, Roberta Ricciarelli, Mariapaola Nitti, Barbara Marengo, Anna Lisa Furfaro, Maria Adelaide Pronzato, Umberto Maria Marinari, Cinzia Domenicotti. Role of Glutathione in Cancer Progression and ChemoresistanceOxidative Medicine and Cellular Longevity 2013; 2013: 1 doi: 10.1155/2013/972913
8
QIWEI LI, XIAOBIN YIN, WEI WANG, MING ZHAN, BENPENG ZHAO, ZHAOYUAN HOU, JIAN WANG. The effects of buthionine sulfoximine on the proliferation and apoptosis of biliary tract cancer cells induced by cisplatin and gemcitabineOncology Letters 2016; 11(1): 474 doi: 10.3892/ol.2015.3879
9
Luis G. Guijarro, Patricia Sanmartin-Salinas, Eva Pérez-Cuevas, M. Val Toledo-Lobo, Jorge Monserrat, Sofía Zoullas, Miguel A. Sáez, Miguel A. Álvarez-Mon, Julia Bujan, Fernando Noguerales-Fraguas, Eduardo Arilla-Ferreiro, Melchor Álvarez-Mon, Miguel A. Ortega. Possible Role of IRS-4 in the Origin of Multifocal Hepatocellular CarcinomaCancers 2021; 13(11): 2560 doi: 10.3390/cancers13112560
10
Mohinder Pal Bansal. Redox Regulation and Therapeutic Approaches in Cancer2023; : 311 doi: 10.1007/978-981-99-7342-2_9
11
Patrick Mäder, Lars Kattner. Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal ChemistryJournal of Medicinal Chemistry 2020; 63(23): 14243 doi: 10.1021/acs.jmedchem.0c00960
12
Gökce Türkkanı, Burcu Güngör, Oğuz Cetin, Çiğdem İçhedef, Yasemin Parlak, F. Gül Gümüşer, B. Elvan Sayıt Bilgin, Serap Teksöz. Synthesis, radiolabeling and in vitro evaluation of azathioprine loaded magnetic solid lipid nanoparticlesJournal of Radioanalytical and Nuclear Chemistry 2023; 332(11): 4695 doi: 10.1007/s10967-023-08975-5
13
Mao-Bin Meng, Huan-Huan Wang, Yao-Li Cui, Zhi-Qiang Wu, Yang-Yang Shi, Nicholas G. Zaorsky, Lei Deng, Zhi-Yong Yuan, You Lu, Ping Wang. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapyOncotarget 2016; 7(35): 57391 doi: 10.18632/oncotarget.10548
14
Adriana Cruz, Pedro Mota, Cristiano Ramos, Rita F. Pires, Cindy Mendes, José P. Silva, Sofia C. Nunes, Vasco D. B. Bonifácio, Jacinta Serpa. Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine Sulfoximine as a Tool to Tackle Ovarian Cancer ChemoresistanceAntioxidants 2020; 9(2): 133 doi: 10.3390/antiox9020133
15
Yuxuan Xiong, Chen Xiao, Zifu Li, Xiangliang Yang. Engineering nanomedicine for glutathione depletion-augmented cancer therapyChemical Society Reviews 2021; 50(10): 6013 doi: 10.1039/D0CS00718H
16
Paolo Mattiolo, Ares Barbero-Farran, Víctor J. Yuste, Jacint Boix, Judit Ribas. 2-Phenylethynesulfonamide (PES) uncovers a necrotic process regulated by oxidative stress and p53Biochemical Pharmacology 2014; 91(3): 301 doi: 10.1016/j.bcp.2014.08.005
17
Claudia Rita Corso, Alexandra Acco. Glutathione system in animal model of solid tumors: From regulation to therapeutic targetCritical Reviews in Oncology/Hematology 2018; 128: 43 doi: 10.1016/j.critrevonc.2018.05.014
18
Camila dos Reis Oliveira, Joedna Cavalcante Pereira, Andressa Barros Ibiapina, Italo Rossi Roseno Martins, João Marcelo de Castro e Sousa, Paulo Michel Pinheiro Ferreira, Felipe Cavalcanti Carneiro da Silva. Buthionine sulfoximine and chemoresistance in cancer treatments: a systematic review with meta-analysis of preclinical studiesJournal of Toxicology and Environmental Health, Part B 2023; 26(8): 417 doi: 10.1080/10937404.2023.2246876
19
Ulrich Lücking. Sulfoximine: Eine vernachlässigte Chance in der medizinischen ChemieAngewandte Chemie 2013; 125(36): 9570 doi: 10.1002/ange.201302209
20
Ulrich Lücking. Sulfoximines: A Neglected Opportunity in Medicinal ChemistryAngewandte Chemie International Edition 2013; 52(36): 9399 doi: 10.1002/anie.201302209
21
Jan Borlinghaus, Jana Foerster (née Reiter), Ulrike Kappler, Haike Antelmann, Ulrike Noll, Martin Gruhlke, Alan Slusarenko. Allicin, the Odor of Freshly Crushed Garlic: A Review of Recent Progress in Understanding Allicin’s Effects on CellsMolecules 2021; 26(6): 1505 doi: 10.3390/molecules26061505
22
Borja Hernández-Breijo, Jorge Monserrat, Irene D. Román, Águeda González-Rodríguez, Mª Dolores Fernández-Moreno, Mª Val T. Lobo, Ángela M. Valverde, Javier P. Gisbert, Luis G. Guijarro. Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1Toxicology and Applied Pharmacology 2013; 272(3): 568 doi: 10.1016/j.taap.2013.07.024
23
Stephan Philipp, Justyna Sosna, Dieter Adam. Cancer and necroptosis: friend or foe?Cellular and Molecular Life Sciences 2016; 73(11-12): 2183 doi: 10.1007/s00018-016-2193-2
24
Sylwia Wrotek, Krzysztof Domagalski, Tomasz Jędrzejewski, Eliza Dec, Wiesław Kozak. Buthionine sulfoximine, a glutathione depletor, attenuates endotoxic fever and reduces IL-1β and IL-6 level in ratsCytokine 2017; 90: 31 doi: 10.1016/j.cyto.2016.10.005
25
Isabel Rodríguez-Gómez, Javier Carmona-Cortés, Rosemary Wangensteen, Pablo Vargas-Tendero, Inmaculada Banegas, Andrés Quesada, Ángel M. García-Lora, Félix Vargas. The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activityTumor Biology 2014; 35(8): 7799 doi: 10.1007/s13277-014-2046-2
26
Qingbin Cui, Jing-Quan Wang, Yehuda G. Assaraf, Liang Ren, Pranav Gupta, Liuya Wei, Charles R. Ashby, Dong-Hua Yang, Zhe-Sheng Chen. Modulating ROS to overcome multidrug resistance in cancerDrug Resistance Updates 2018; 41: 1 doi: 10.1016/j.drup.2018.11.001